Wang Xiaodong

This profile gathers the share dealings of Wang Xiaodong across 2 companies, led by BeOne Medicines Ltd. and Clover Biopharmaceuticals, Ltd. - B. The record holds 388 filings, for trades running from 23 November 2016 to 13 October 2026.

On the open market, the record shows 6 purchases and 306 sales worth €163.7M. The amount is not disclosed for 23 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 9 share grants and 14 option exercises. Since January 2026: 2 purchases and 26 sales on the market.

On 16 October 2026 came the latest disclosure, an open-market sale for €1.2M in BeOne Medicines Ltd. The last purchase on record was published on 16 June 2026, which is 130 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 2 days. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.